Biocatalysis in development of green pharmaceutical processes

被引:202
作者
Tao, Junhua [1 ]
Xu, Jian-He [2 ]
机构
[1] Elevance Renewable Sci Inc, Bolingbrook, IL 60440 USA
[2] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
关键词
ENANTIOSELECTIVE SYNTHESIS; CHEMOENZYMATIC SYNTHESIS; SIDE-CHAIN; EFFICIENT;
D O I
10.1016/j.cbpa.2009.01.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biocatalysis is one of the greenest technologies for the synthesis of chiral molecules due to exquisite regioselectivity and stereoselectivity in water under mild conditions. For example, protection and deprotection of functional groups are usually not required for biotransformations, high or low temperature reactions can often be circumvented and usage of organic solvents are drastically minimized. To truly empower the green chemistry feature of biocatalysis, it is essential to integrate enzymatic transformations strategically into chemical transformations at the retrosynthetic level. This review focuses on the development of novel biocatalytic pharmaceutical processes to replace chemical routes with poorer process efficiency and higher manufacturing costs.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 25 条
[11]   Development of an efficient, scalable, aldolase-catalyzed process for enantioselective synthesis of statin intermediates [J].
Greenberg, WA ;
Varvak, A ;
Hanson, SR ;
Wong, K ;
Huang, HJ ;
Chen, P ;
Burk, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :5788-5793
[12]   Chemical development of CI-1008, an enantiomerically pure anticonvulsant [J].
Hoekstra, MS ;
Sobieray, DM ;
Schwindt, MA ;
Mulhern, TA ;
Grote, TM ;
Huckabee, BK ;
Hendrickson, VS ;
Franklin, LC ;
Granger, EJ ;
Karrick, GL .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1997, 1 (01) :26-38
[13]  
HOFFMAN WF, 1986, J MED CHEM, V29, P849, DOI 10.1021/jm00155a040
[14]  
HU S, 2006, Patent No. 2006134482
[15]   Directed evolution of an industrial biocatalyst: 2-deoxy-d-ribose 5-phosphate aldolase [J].
DSM Anti-Infectives, Delft, Netherlands ;
不详 ;
不详 ;
不详 .
Biotechnol. J., 2006, 5 (537-548) :537-548
[16]   Development of a chemoenzymatic manufacturing process for pregabalin [J].
Martinez, Carlos A. ;
Hu, Shanghui ;
Dumond, Yves ;
Tao, Junhua ;
Kelleher, Patrick ;
Tully, Liam .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (03) :392-398
[17]   Chemo-enzymatic synthesis of pharmaceutical intermediates [J].
Patel, Ramesh N. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (02) :187-245
[18]   Biocatalysis for pharmaceutical intermediates: the future is now [J].
Pollard, David J. ;
Woodley, John M. .
TRENDS IN BIOTECHNOLOGY, 2007, 25 (02) :66-73
[19]   Recent applications of biocatalysis in developing green chemistry for chemical synthesis at the industrial scale [J].
Ran, Ningqing ;
Zhao, Lishan ;
Chen, Zhenming ;
Tao, Junhua .
GREEN CHEMISTRY, 2008, 10 (04) :361-372
[20]   E factors, green chemistry and catalysis: an odyssey [J].
Sheldon, Roger A. .
CHEMICAL COMMUNICATIONS, 2008, (29) :3352-3365